Literature DB >> 4069346

Treatment of mania using a calcium antagonist--preliminary trial.

V Caillard.   

Abstract

A study was undertaken on the effects on pure manic syndromes of the reduction of intracytoplasmic ionized calcium by administration of a calcium antagonist. Four well-known bipolar patients (manic type) were significantly improved. 1 patient was rapidly cured, though in this case (first attack in a young man) the possibility of spontaneous remission could not be excluded. 2 patients showed no improvement, suffering from a secondary manic state related to the onset of cerebral atrophy. If confirmed, these results should orientate future research in primary manic syndromes and in the mode of action of lithium on calcium metabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4069346     DOI: 10.1159/000118196

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  6 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Do calcium antagonists have a place in the treatment of mood disorders?

Authors:  C Höschl
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

4.  Diltiazem as augmentation therapy in patients with treatment-resistant bipolar disorder: a retrospective study.

Authors:  P H Silverstone; L Birkett
Journal:  J Psychiatry Neurosci       Date:  2000-05       Impact factor: 6.186

5.  Effects of lithium on synaptosomal Ca2+ fluxes.

Authors:  M L Koenig; R S Jope
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 6.  A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

Authors:  A Cipriani; K Saunders; M-J Attenburrow; J Stefaniak; P Panchal; S Stockton; T A Lane; E M Tunbridge; J R Geddes; P J Harrison
Journal:  Mol Psychiatry       Date:  2016-05-31       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.